Related Experiment Videos
Infective agents and cardiovascular disease.
1Department of Population Health Sciences, University of Wisconsin Medical School, Madison, Wisconsin 53705, USA. fjnieto@wisc.edu
Seminars in Vascular Medicine
|October 14, 2005
Summary
Infections are increasingly recognized as potential risk factors for atherosclerosis and cardiovascular disease. Research explores links between chronic infections and heart disease, with ongoing debate and future research directions.
Area of Science:
- Cardiovascular Science
- Infectious Disease Epidemiology
Background:
- Infections are emerging as potential risk factors for atherosclerosis.
- Inflammation plays a key role in atherogenesis and atherosclerotic plaque development.
- Decades of research have investigated the link between chronic infections and cardiovascular disease (CVD).
Purpose of the Study:
- To review the evidence linking infectious agents to atherosclerosis and cardiovascular disease.
- To discuss limitations and methodological issues in current research.
- To present supporting evidence from pathology and animal studies.
Main Methods:
- Review of clinical and epidemiological studies on infection markers and CVD outcomes.
- Analysis of pathology studies identifying infectious agents' DNA in atherosclerotic plaques.
- Examination of experimental infection models in animals.
Main Results:
- Numerous studies show inconsistent results regarding the association between various infectious agents (e.g., cytomegalovirus, Chlamydia pneumoniae) and CVD.
- Pathology and animal studies provide supporting evidence for infectious agents in atherosclerotic plaques.
- Methodological limitations complicate the interpretation of existing epidemiological data.
Conclusions:
- The role of infections in atherosclerosis remains an area of active investigation.
- Further research is needed to clarify the complex relationship between specific pathogens and cardiovascular health.
- Addressing methodological challenges is crucial for advancing our understanding of infectious risk factors for CVD.